📌 Key Takeaways
- Topic: Silica Exporter Guide: Export Documents, Packaging and Shipping Terms
- Keywords: silica thermal insulation
- Published: 2026-11-20 05:22:45
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
High Purity Silica: Purity Levels (4N–6N), Specifications and Applications
- What Is Silica Powder? Types, Particle Sizes, Grades and Common Applications
- Top Fumed Silica Manufacturers: Global Leaders and Emerging Suppliers (2026)
- Silica for Tires: How It Reduces Rolling Resistance and Improves Wet Grip
- Auzel, F. Upconversion and anti-stokes processes with f and d ions in solids. Chem. Rev. 104, 139-174 (2004). Post CAS PubMed Google Scholar
- Crystalline Silica Dust Hazard: Health Risks and How to Protect Workers
- Yang, Q. et al. Engineering 2D mesoporous Silica@MXene‐integrated 3D‐printing scaffolds for combinatory osteosarcoma therapy and NO‐augmented bone regeneration. Tiny 16, 1906814 (2020). Piece CAS Google Scholar
Silicone vs Silica: What Is the Difference and Where Is Each Used?
What is silica (SiO₂)?
Syloid silica Hu, C.-M. J. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980-10985 (2011). Post CAS PubMed Central PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
matting agent supplier
What drives silica raw material prices?
silica flow agent The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.